Balchem Co. (NASDAQ:BCPC) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. grew its position in shares of Balchem Co. (NASDAQ:BCPCFree Report) by 129.7% during the 3rd quarter, Holdings Channel reports. The firm owned 98,853 shares of the basic materials company’s stock after purchasing an additional 55,822 shares during the period. Victory Capital Management Inc.’s holdings in Balchem were worth $17,398,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of BCPC. Janney Montgomery Scott LLC increased its position in shares of Balchem by 53.5% during the 1st quarter. Janney Montgomery Scott LLC now owns 2,977 shares of the basic materials company’s stock valued at $461,000 after purchasing an additional 1,038 shares during the period. State Board of Administration of Florida Retirement System boosted its stake in shares of Balchem by 11.1% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 10,162 shares of the basic materials company’s stock worth $1,575,000 after acquiring an additional 1,017 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Balchem by 3.8% during the 1st quarter. Vanguard Group Inc. now owns 3,935,935 shares of the basic materials company’s stock worth $609,873,000 after acquiring an additional 144,423 shares in the last quarter. O Shaughnessy Asset Management LLC bought a new stake in shares of Balchem during the 1st quarter worth $321,000. Finally, UniSuper Management Pty Ltd bought a new stake in shares of Balchem during the 1st quarter worth $1,049,000. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Balchem Stock Performance

Shares of Balchem stock opened at $177.53 on Wednesday. The stock has a market cap of $5.77 billion, a PE ratio of 47.72, a price-to-earnings-growth ratio of 5.31 and a beta of 0.65. The business has a fifty day simple moving average of $173.11 and a 200-day simple moving average of $166.15. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. Balchem Co. has a 12 month low of $120.76 and a 12 month high of $186.03.

Wall Street Analysts Forecast Growth

BCPC has been the subject of several research reports. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright raised their target price on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Monday, November 4th.

Read Our Latest Research Report on BCPC

About Balchem

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Featured Stories

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPCFree Report).

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.